Clinacanthus nutans leaf extract prevents metabolic dysfunction-associated steatotic liver (MASL) to metabolic dysfunction-associated steatohepatitis (MASH) progression in western diet-fed C57BL/6 mice
Authors/Creators
- 1. Universitas Airlangga, Surabaya, Indonesia|Oita University, Yufu, Japan
- 2. Universitas Airlangga, Surabaya, Indonesia
- 3. Oita University, Yufu, Japan
Description
The phytochemical profile and hepatoprotective, antioxidant, and lipid-modulating effects of the ethanolic extract of Clinacanthus nutans leaves were examined in male C57BL/6 mice fed a cholesterol-supplemented western diet. After 15 weeks of feeding, the untreated mice developed steatosis, lobular inflammation, and ballooning hepatocytes, with NAFLD activity scores ≥5, indicative of metabolic dysfunction-associated steatohepatitis (MASH). Treatment with Clinacanthus nutans extract at doses of 100, 200, and 400 mg/kg from week 8 to 15 significantly reduced the liver-to-body weight ratio and NAFLD activity score, with dose-dependent histological improvement, particularly reduced lobular inflammation. AST, ALT, and hepatic malondialdehyde levels were significantly lowered in the treated groups, with effects exceeding those of atorvastatin. However, Clinacanthus nutans extract did not attenuate the elevated LDL-to-HDL ratio. In conclusion, Clinacanthus nutans extract effectively prevented the progression from simple steatosis to steatohepatitis, likely through antioxidative mechanisms attributable to its high tannin content.
Files
PHAR_article_162588.pdf
Additional details
References
- Alam A, Ferdosh S, Ghafoor K, Hakim A, Juraimi AS, Khatib A, Sarker ZI (2016) Clinacanthus nutans: A review of the medicinal uses, pharmacology and phytochemistry. Asian Pacific Journal of Tropical Medicine 9: 402–409. https://doi.org/10.1016/j.apjtm.2016.03.011
- Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K (2023) Oxidative Stress in Liver Pathophysiology and Disease. Antioxidants 12: 1653. https://doi.org/10.3390/antiox12091653
- Arjmand A, Tsipouras MG, Tzallas AT, Forlano R, Manousou P, Giannakeas N (2020) Quantification of Liver Fibrosis – A Comparative Study. Applied Sciences 10: 447. https://doi.org/10.3390/app10020447
- Arslan U, Yenerçağ M (2020) Relationship between non-alcoholic fatty liver disease and coronary heart disease. World Journal of Clinical Cases 8: 4688–4699. https://doi.org/10.12998/wjcc.v8.i20.4688
- Branković M, Dukić M, Gmizić T, Popadić V, Nikolić N, Sekulić A, Brajković M, Đokić J, Mahmutović E, Lasica R, Vojnović M, Milovanović T (2024) New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk. Diagnostics 14: 229. https://doi.org/10.3390/diagnostics14020229
- Carpino G, Morini S, Ginannicorradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onettimuda A, Berloco P, Rossi M (2005) Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Digestive and Liver Disease 37: 349–356. https://doi.org/10.1016/j.dld.2004.11.009
- Chen H, Zhan Y, Zhang J, Cheng S, Zhou Y, Chen L, Zeng Z (2022) The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019. JMIR Public Health and Surveillance 8: e34809. https://doi.org/10.2196/34809
- Chia TY, Gan CY, Murugaiyah V, Hashmi SF, Fatima T, Ibrahim L, Abdulla MH, Alswailmi FK, Johns EJ, Ahmad A (2021) A Narrative Review on the Phytochemistry, Pharmacology and Therapeutic Potentials of Clinacanthus nutans (Burm. f.) Lindau Leaves as an Alternative Source of Future Medicine. Molecules 27: 139. https://doi.org/10.3390/molecules27010139
- Chiang Morales MD, Chang C-Y, Le VL, Huang I-T, Tsai I-L, Shih H-J, Huang C-J (2022) High-Fructose/High-Fat Diet Downregulates the Hepatic Mitochondrial Oxidative Phosphorylation Pathway in Mice Compared with High-Fat Diet Alone. Cells 11: 3425. https://doi.org/10.3390/cells11213425
- Clemente-Suárez VJ, Beltrán-Velasco AI, Redondo-Flórez L, Martín-Rodríguez A, Tornero-Aguilera JF (2023) Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review. Nutrients 15: 2749. https://doi.org/10.3390/nu15122749
- Elgailani IEH, Ishak CY (2014) Determination of Tannins of Three Common Acacia Species of Sudan. Advances in Chemistry 2014: 1–5. https://doi.org/10.1155/2014/192708
- Fan J-G, Xu X-Y, Yang R-X, Nan Y-M, Wei L, Jia J-D, Zhuang H, Shi J-P, Li X-Y, Sun C, Li J, Wong VW-S, Duan Z-P (2024) Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024). Journal of Clinical and Translational Hepatology 000: 000–000. https://doi.org/10.14218/JCTH.2024.00311
- Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, Adams LA, Boursier J, Papatheodoridis G, El-Kassas M, Méndez-Sánchez N, Sookoian S, Castera L, Chan W-K, Ye F, Treeprasertsuk S, Cortez-Pinto H, Yu HH, Kim W, Romero-Gómez M, Nakajima A, Win KM, Kim SU, Holleboom AG, Sebastiani G, Ocama P, Ryan JD, Lupșor-Platon M, Ghazinyan H, Al-Mahtab M, Hamid S, Perera N, Alswat KA, Pan Q, Long MT, Isakov V, Mi M, Arrese M, Sanyal AJ, Sarin SK, Leite NC, Valenti L, Newsome PN, Hagström H, Petta S, Yki-Järvinen H, Schattenberg JM, Castellanos Fernández MI, Leclercq IA, Aghayeva G, Elzouki A-N, Tumi A, Sharara AI, Labidi A, Sanai FM, Matar K, Al-Mattooq M, Akroush MW, Benazzouz M, Debzi N, Alkhatry M, Barakat S, Al-Busafi SA, Rwegasha J, Yang W, Adwoa A, Opio CK, Sotoudeheian M, Wong YJ, George J, Zheng M-H (2025) Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Reports 7: 101271. https://doi.org/10.1016/j.jhepr.2024.101271
- Geng Y, Faber KN, De Meijer VE, Blokzijl H, Moshage H (2021) How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatology International 15: 21–35. https://doi.org/10.1007/s12072-020-10121-2
- Hasanatuludhhiyah N, Mustika A, Kalanjati VP, Miftahussurur M, Uemura N (2025a) Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmaceuticals 18: 1276. https://doi.org/10.3390/ph18091276
- Hasanatuludhhiyah N, Mustika A, Kalanjati VP, Haq KU, Miftahussurur M, Wakuda H, Uemura N (2025b) Predicting activities of Clinacanthus nutans (Burm.f.) Lindau metabolites against molecular targets in metabolic dysfunction-associated steatotic liver disease. Journal of Pharmacy & Pharmacognosy Research 13(s1): S316–S332. https://doi.org/10.56499/jppres24.2246_13.s1.316
- Hong S, Sun L, Hao Y, Li P, Zhou Y, Liang X, Hu J, Wei H (2024) From NAFLD to MASLD: When metabolic comorbidity matters. Annals of Hepatology 29: 101281. https://doi.org/10.1016/j.aohep.2023.101281
- Jiang ZG, Mukamal K, Tapper E, Robson SC, Tsugawa Y (2014) Low LDL-C and High HDL-C Levels Are Associated with Elevated Serum Transaminases amongst Adults in the United States: A Cross-sectional Study. Sookoian SC (Ed.). PLoS ONE 9: e85366. https://doi.org/10.1371/journal.pone.0085366
- Jiang ZG, Tsugawa Y, Tapper EB, Lai M, Afdhal N, Robson SC, Mukamal KJ (2015) Low‐fasting triglyceride levels are associated with non‐invasive markers of advanced liver fibrosis among adults in the United States. Alimentary Pharmacology & Therapeutics 42: 106–116. https://doi.org/10.1111/apt.13216
- Jing W, Xiaolan C, Yu C, Feng Q, Haifeng Y (2022) Pharmacological effects and mechanisms of tannic acid. Biomedicine & Pharmacotherapy 154: 113561. https://doi.org/10.1016/j.biopha.2022.113561
- Kawano Y, Cohen DE (2013) Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. Journal of Gastroenterology 48: 434–441. https://doi.org/10.1007/s00535-013-0758-5
- Kong HS, Abdullah Sani N (2019) Qualitative and Quantitative Phytochemical Analysis and Antioxidant Properties of Leaves and Stems of Clinacanthus nutans (Burm. f.) Lindau from Two Herbal Farms of Negeri Sembilan, Malaysia. ASM Science Journal 12: 1–13. https://doi.org/10.32802/asmscj.2019.87
- Lekakis V, Papatheodoridis GV (2024) Natural history of metabolic dysfunction-associated steatotic liver disease. European Journal of Internal Medicine 122: 3–10. https://doi.org/10.1016/j.ejim.2023.11.005
- Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Després J-P (2001) Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study. Archives of Internal Medicine 161: 2685–2692. https://doi.org/10.1001/archinte.161.22.2685
- Liu Y, Cheng Z, Ding L, Fang F, Cheng K-A, Fang Q, Shi G-P (2010) Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin. Int. Journal of Clinical Pharmacology and Therapeutics 48: 798–802. https://doi.org/10.5414/CPP48798
- Mustika A, Fatimah N, Safitri I, Susanti N, Noor NS (2023) Clinacanthus nutans L Extracts Reduce the Serum Tumor Necrosis Factor-α, Malondialdehyde, and Interleukin-6 Levels and Improve the Langerhans Islet Area in Diabetic Rat Models. Clinical Medicine Insights: Endocrinology and Diabetes 16: 11795514231196462. https://doi.org/10.1177/11795514231196462
- Ng KS, Tan S-A, Bok CY, Loh KE, Ismail IS, Yue CS, Loke CF (2022) Metabolomic Approach for Rapid Identification of Antioxidants in Clinacanthus nutans Leaves with Liver Protective Potential. Molecules 27: 3650. https://doi.org/10.3390/molecules27123650
- Ngoc QN, Van HNH, Ngoc BNT, Cong HN, Cam QNT (2023) Chemical composition, total phenolics, flavonoids and antioxidant activity of the Clinacanthus nutans extract. AIP Conference Proceedings 2779: 030017. https://doi.org/10.1063/5.0142553
- Nicolescu A, Bunea CI, Mocan A (2025) Total flavonoid content revised: An overview of past, present, and future determinations in phytochemical analysis. Analytical Biochemistry 700: 115794. https://doi.org/10.1016/j.ab.2025.115794
- Nimyel CD, Lori JA (2023) Phytochemistry, Proximate Analysis and Acute Toxicity Study of Ethanolic Moringa Oleifera Root Bark Extract. Nigerian Journal of Chemical Research 27: 025–034. https://doi.org/10.4314/njcr.v27i1.3
- Parthasarathy G, Revelo X, Malhi H (2020) Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. Hepatology Communications 4: 478–492. https://doi.org/10.1002/hep4.1479
- Pastori D, Pani A, Di Rocco A, Menichelli D, Gazzaniga G, Farcomeni A, D'Erasmo L, Angelico F, Del Ben M, Baratta F (2022) Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis. British Journal of Clinical Pharmacology 88: 441–451. https://doi.org/10.1111/bcp.14943
- Pérez M, Dominguez-López I, Lamuela-Raventós RM (2023) The Chemistry Behind the Folin–Ciocalteu Method for the Estimation of (Poly)phenol Content in Food: Total Phenolic Intake in a Mediterranean Dietary Pattern. Journal of Agricultural and Food Chemistry 71: 17543–17553. https://doi.org/10.1021/acs.jafc.3c04022
- Sanyal AJ, Husain M, Diab C, Mangla KK, Shoeb A, Lingvay I, Tapper EB (2024) Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review. American Heart Journal Plus: Cardiology Research and Practice 41: 100386. https://doi.org/10.1016/j.ahjo.2024.100386
- Sarega N, Imam MU, Esa NM, Zawawi N, Ismail M (2016a) Effects of phenolic-rich extracts of Clinacanthus nutans on high fat and high cholesterol diet-induced insulin resistance. BMC Complementary and Alternative Medicine 16: 88. https://doi.org/10.1186/s12906-016-1049-5
- Sarega N, Imam MU, Ooi D-J, Chan KW, Md Esa N, Zawawi N, Ismail M (2016b) Phenolic Rich Extract from Clinacanthus nutans Attenuates Hyperlipidemia‐Associated Oxidative Stress in Rats. Abdel Moneim A (Ed.). Oxidative Medicine and Cellular Longevity 2016: 4137908. https://doi.org/10.1155/2016/4137908
- Sun T, Chen M, Shen H, Ping Yin, Fan L, Chen X, Wu J, Xu Z, Zhang J (2022) Predictive value of LDL/HDL ratio in coronary atherosclerotic heart disease. BMC Cardiovascular Disorders 22: 273. https://doi.org/10.1186/s12872-022-02706-6
- Susanti N, Mustika A, Khotib J (2024a) Clinacanthus nutans leaf extract reduces pancreatic β-cell apoptosis by inhibiting JNK activation and modulating oxidative stress and inflammation in Streptozotocin-induced diabetic rats. Open Veterinary Journal 14: 730. https://doi.org/10.5455/OVJ.2024.v14.i2.13
- Susanti N, Mustika A, Khotib J, Muti'ah R, Rochmanti M (2023) Phytochemical, Metabolite Compound, and Antioxidant Activity of Clinacanthus nutans Leaf Extract from Indonesia. Science and Technology Indonesia 8: 38–44. https://doi.org/10.26554/sti.2023.8.1.38-44
- Susanti N, Akbar PW, Suwondo ASN, Silahudin F, Khafiralia M, Reviansyah MDA, Syukri NAA, Mashuri RF (2024b) Protective Role of Clinacanthus nutans Against Liver Damage in Streptozotocin-induced Diabetic Rats. Malaysian Journal of Medicine and Health Sciences 20: 19–24. https://doi.org/10.47836/mjmhs.20.6.4
- Syed-Abdul MM (2023) Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD). Metabolites 14: 12. https://doi.org/10.3390/metabo14010012
- Takahashi Y (2014) Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World Journal of Gastroenterology 20: 15539. https://doi.org/10.3748/wjg.v20.i42.15539
- Vacca M, Kamzolas I, Harder LM, Oakley F, Trautwein C, Hatting M, Ross T, Bernardo B, Oldenburger A, Hjuler ST, Ksiazek I, Lindén D, Schuppan D, Rodriguez-Cuenca S, Tonini MM, Castañeda TR, Kannt A, Rodrigues CMP, Cockell S, Govaere O, Daly AK, Allison M, Honnens De Lichtenberg K, Kim YO, Lindblom A, Oldham S, Andréasson A-C, Schlerman F, Marioneaux J, Sanyal A, Afonso MB, Younes R, Amano Y, Friedman SL, Wang S, Bhattacharya D, Simon E, Paradis V, Burt A, Grypari IM, Davies S, Driessen A, Yashiro H, Pors S, Worm Andersen M, Feigh M, Yunis C, Bedossa P, Stewart M, Cater HL, Wells S, Schattenberg JM, Anstee QM, Anstee QM, Daly AK, Cockell S, Tiniakos D, Bedossa P, Burt A, Oakley F, Cordell HJ, Day CP, Wonders K, Missier P, McTeer M, Vale L, Oluboyede Y, Breckons M, Boyle J, Bossuyt PM, Zafarmand H, Vali Y, Lee J, Nieuwdorp M, Holleboom AG, Angelakis A, Verheij J, Ratziu V, Clément K, Patino-Navarrete R, Pais R, Paradis V, Schuppan D, Schattenberg JM, Surabattula R, Myneni S, Kim YO, Straub BK, Vidal-Puig A, Vacca M, Rodrigues-Cuenca S, Allison M, Kamzolas I, Petsalaki E, Campbell M, Lelliott CJ, Davies S, Orešič M, Hyötyläinen T, McGlinchey A, Mato JM, Millet Ó, Dufour J-F, Berzigotti A, Masoodi M, Lange NF, Pavlides M, Harrison S, Neubauer S, Cobbold J, Mozes F, Akhtar S, Olodo-Atitebi S, Banerjee R, Shumbayawonda E, Dennis A, Andersson A, Wigley I, Romero-Gómez M, Gómez-González E, Ampuero J, Castell J, Gallego-Durán R, Fernández-Lizaranzu I, Montero-Vallejo R, Karsdal M, Rasmussen DGK, Leeming DJ, Sinisi A, Musa K, Sandt E, Tonini MM, Bugianesi E, Rosso C, Armandi A, Marra F, Gastaldelli A, Svegliati G, Boursier J, Francque S, Vonghia L, Verrijken A, Dirinck E, Driessen A, Ekstedt M, Kechagias S, Yki-Järvinen H, Porthan K, Arola J, Van Mil S, Papatheodoridis G, Cortez-Pinto H, Silva AP, Rodrigues CMP, Valenti L, Pelusi S, Petta S, Pennisi G, Miele L, Liguori A, Geier A, Rau M, Trautwein C, Reißing J, Aithal GP, Francis S, Palaniyappan N, Bradley C, Hockings P, Schneider M, Newsome PN, Hübscher S, Wenn D, Magnanensi J, Trylesinski A, Mayo R, Alonso C, Duffin K, Perfield JW, Chen Y, Hartman ML, Yunis C, Miller M, Chen Y, McLeod EJ, Ross T, Bernardo B, Schölch C, Ertle J, Younes R, Coxson H, Simon E, Gogain J, Ostroff R, Alexander L, Biegel H, Kjær MS, Harder LM, Al-Sari N, Veidal SS, Oldenburger A, Ellegaard J, Balp M-M, Jennings L, Martic M, Löffler J, Applegate D, Torstenson R, Lindén D, Fournier-Poizat C, Llorca A, Kalutkiewicz M, Pepin K, Ehman R, Horan G, Ho G, Tai D, Chng E, Xiao T, Patterson SD, Billin A, Doward L, Twiss J, Thakker P, Derdak Z, Yashiro H, Landgren H, Lackner C, Gouw A, Hytiroglou P, Govaere O, Brass C, Tiniakos D, Perfield JW, Petsalaki E, Davidsen P, Vidal-Puig A (2024) An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature Metabolism 6: 1178–1196. https://doi.org/10.1038/s42255-024-01043-6
- Van Herck M, Vonghia L, Francque S (2017) Animal Models of Nonalcoholic Fatty Liver Disease – A Starter's Guide. Nutrients 9: 1072. https://doi.org/10.3390/nu9101072
- Vrentzos E, Pavlidis G, Korakas E, Kountouri A, Pliouta L, Dimitriadis GD, Lambadiari V (2025) Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health. Nutrients 17: 1657. https://doi.org/10.3390/nu17101657
- Younossi ZM, Kalligeros M, Henry L (2025) Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology 31: S32–S50. https://doi.org/10.3350/cmh.2024.0431
- Yun B, Park H, Lee J, Kim BK, Yoon J-H (2025) Statin use and liver-related prognosis among patients with MASLD. JHEP Reports 7: 101313. https://doi.org/10.1016/j.jhepr.2024.101313
- Zhang R, Lu Z, Xu Y, Peng Q, Xiao M, Sang S (2023) Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics. Khan W (Ed.). Evidence-Based Complementary and Alternative Medicine 2023: 5625222. https://doi.org/10.1155/2023/5625222
- Zhang S, Ren X, Zhang B, Lan T, Liu B (2024) A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action. Molecules 29: 1859. https://doi.org/10.3390/molecules29081859
- Zhang X, Hartmann P (2023) How to calculate sample size in animal and human studies. Frontiers in Medicine 10: 1215927. https://doi.org/10.3389/fmed.2023.1215927